Publication | Closed Access

iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates

Neurodegenerative DiseasesMolecular NeuroscienceNovel Therapeutic CandidatesParkinson DiseaseDegenerative DiseaseNeurochemical BiomarkersNeurologyNeuroscienceNeurodegenerationIpsc ModelingMolecular SignatureMedicineSynaptic SignalingMolecular NeurobiologySocial Sciences